What people are saying - Write a review
We haven't found any reviews in the usual places.
Orphan Products Development and Some Methods for Maximizing
The Orphan Products Board of the Department of Health Human Services
12 other sections not shown
academic ADD program Alan Anticonvulsant antiepileptic drugs applications approval Association bladder Brewer GJ Center clinical studies clinical trials Commission compound cooperation cysteamine cystine cystinosis development of orphan diagnosis Drug and Device drug development program Editors Vol Epilepsy Epilepsy Branch evaluation federal funding Goldstein GPIA Horansky initial interstitial cystitis investigators involved legislation Liss marketing MDA's Medicine New York Mount Sinai School Myoclonus National Institutes National Organization neuromuscular diseases NORD number of patients Organization for Rare orphan diseases Orphan Drug Act orphan drug development orphan drug research Orphan Products Board Orphan Products Development orphan treatment pantethine penicillamine Ph.D pharmaceutical company pharmaceutical industry Phase physicians potential Prasad preclinical projects rare diseases rare disorders research and development SBIR School of Medicine scientists screening small business sponsors testing Tourette Syndrome Tourette Syndrome Association toxicity toxicology treatment development Wilson's disease Woert